4//SEC Filing
Wendel Bruce 4
Accession 0001364846-25-000007
CIK 0001326110other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:55 PM ET
Size
6.1 KB
Accession
0001364846-25-000007
Insider Transaction Report
Form 4
Wendel Bruce
Director
Transactions
- Award
Stock Option (right to buy)
2025-12-12+146,020→ 146,020 totalExercise: $2.36Exp: 2035-12-12→ Common Stock (146,020 underlying)
Footnotes (1)
- [F1]Subject to the reporting person's continuing to be a Service Provider (as defined in the 2025 Equity Incentive Plan) through each applicable vesting date, 48,673 of the shares subject to the award will vest on December 12, 2026, 48,673 of the shares subject to the award will vest on December 12, 2027 and 48,674 of the shares subject to the award will vest on December 12, 2028, such that the award will be fully vested on December 12, 2028; provided that, notwithstanding the foregoing, any unvested shares subject to the award will fully vest immediately prior to a Change in Control (as defined in the 2025 Equity Incentive Plan), subject to the reporting person continuing to be a Service Provider through the date of such Change in Control.
Documents
Issuer
ImmunityBio, Inc.
CIK 0001326110
Entity typeother
Related Parties
1- filerCIK 0001364846
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 5:55 PM ET
- Size
- 6.1 KB